Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / RCUS - Arcus Biosciences: A Preview Of Their Outlook Ahead Of ASCO

RCUS - Arcus Biosciences: A Preview Of Their Outlook Ahead Of ASCO

Arcus Biosciences Inc.

2024-05-15 03:38:24 ET

Summary

  • Arcus Biosciences is preparing for a readout at the ASCO Annual Meeting, which could be a significant catalyst for the company.
  • The company has a strong financial position with $1.1 billion in current assets, but has a quarterly loss of $4 million.
  • Arcus Biosciences has several clinical candidates in its pipeline, with a focus on domvanalimab and etrumadenant at ASCO 2024.

Topline Summary and Update

For further details see:

Arcus Biosciences: A Preview Of Their Outlook Ahead Of ASCO
Stock Information
Company Name: Arcus Biosciences Inc.
Stock Symbol: RCUS
Market: NYSE
Website: arcusbio.com
Menu
RCUS RCUS Quote RCUS Short RCUS News RCUS Articles RCUS Message Board
Get RCUS Alerts

News, Short Squeeze, Breakout and More Instantly...